Dr. Jenny Ting received her B.S. from Illinois State University as the recipient of a Foreign Student scholarship and her Ph.D. in Microbiology and Immunology from Northwestern University. After graduation, she pursued post-doctoral training at the University of Southern California with Drs. Jeffrey Frelinger and Leslie Weiner where she first described the presence of immune response markers (MHCII) in the brain and the migration of cells in the immune system into the brain. She then pursued postdoctoral training at Duke University with Dr. Bernard Amos, where she initiated her longstanding work in the control of MHCII genes. She joined the faculty of the University of North Carolina at Chapel Hill as an assistant professor, and was awarded an Alumni Distinguished Professorship in 1997. In 2008 she became the Director of the Center for Translational Immunology and in 2009 she was awarded the William Rand Kenan Professor of Microbiology/Immunology. She currently heads the Immunology Program at the Lineberger Comprehensive Cancer Center. She also has over 200 publications at present. Dr. Ting's scientific work spans a broad number of fields including molecular genetics, basic immunology, infectious diseases, cancer biology and treatment, transplantation, asthma, allergy, and neuro-inflammation. She has utilized cutting edge genomics and proteomics approaches to identify important novel genes and proteins in a number of diseases.